Minerva Neurosciences (NERV) Depreciation & Amortization (CF) (2014 - 2025)
Minerva Neurosciences (NERV) posted Depreciation & Amortization (CF) of $1360.0 for Q4 2025, little changed on a QoQ basis from $1361.0 in Q3 2025, and little changed year-over-year from $1360.0 in Q4 2024.
Minerva Neurosciences (NERV) Depreciation & Amortization (CF) (2014 - 2025) Analysis & Trends
Minerva Neurosciences' Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $1360.0 for Q4 2025.
- Quarterly Depreciation & Amortization (CF) changed 0.0% year-over-year to $1360.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $4081.0 (down 25.02% YoY) and the FY2025 annual result came in at $5442.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) was $1360.0 for Q4 2025 at Minerva Neurosciences, roughly flat from $1361.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1361.0 in Q2 2023 and bottomed at $1360.0 in Q1 2023.
- A 3-year average of $1360.5 and a median of $1360.5 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Peak annual rise in Depreciation & Amortization (CF) reached 0.07% in 2024, while the deepest fall reached 0.07% in 2024.
- Minerva Neurosciences' Depreciation & Amortization (CF) stood at $1361.0 in 2023, then dropped by 0.07% to $1360.0 in 2024, then changed by 0.0% to $1360.0 in 2025.
- Business Quant data shows NERV's Depreciation & Amortization (CF) at $1360.0 in Q4 2025, $1361.0 in Q3 2025, and $1360.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,360.00 |
| Dec 31, 2025 | 1,360.00 |
| Sep 30, 2025 | 1,361.00 |
| Sep 30, 2025 | 1,361.00 |
| Jun 30, 2025 | 1,360.00 |
| Jun 30, 2025 | 1,360.00 |
| Mar 31, 2025 | 1,361.00 |
| Mar 31, 2025 | 1,361.00 |
| Dec 31, 2024 | 1,360.00 |
| Dec 31, 2024 | 1,360.00 |
| Sep 30, 2024 | 1,361.00 |
| Sep 30, 2024 | 1,361.00 |
| Jun 30, 2024 | 1,361.00 |
| Jun 30, 2024 | 1,361.00 |
| Mar 31, 2024 | 1,360.00 |
| Mar 31, 2024 | 1,360.00 |
| Dec 31, 2023 | 1,361.00 |
| Dec 31, 2023 | 1,361.00 |
| Sep 30, 2023 | 1,360.00 |
| Sep 30, 2023 | 1,360.00 |